The University of Texas MD Anderson Cancer Center is seeking a highly qualified postdoctoral fellow candidate in Dr. Michael Wang's lab. This is a full-time, hands-on laboratory research position. We are seeking highly motivated colleagues who are interested in applying their knowledge to in vivo tumor models, functional genomics using CRISPR-Cas9 technology, cancer biology, cell signaling, molecular biology, and pharmacology to ultimately solve therapeutic challenges in lymphoma. This position focuses on the integration and analysis of patient-derived xenograft models to understand patterns of therapeutic response and genetic drivers of resistance.

LEARNING OBJECTIVES
Dr. Michael Wang's lab is part of the Department of Lymphoma & Myeloma, which offers a highly translational research environment. The lab is well funded through the NIH/NCI grants (two R01s), two Leukemia and Lymphoma Society grants, a CPRIT grant, research consortia, and other funding mechanisms.

ELIGIBILITY REQUIREMENTS
Requirements: Individuals with a PhD degree in bioinformatics, genomics, molecular biology, cancer biology or a related field are encouraged to apply. Must have experience with animal models. Experience with next-generation sequencing and/or ChIP-seq, ATAC-seq, Hi-C, or other large-scale epigenomics data analysis is highly desirable. A good understanding of cancer biology, cell signaling pathways, or drug response mechanisms is also desirable. Interested applicants are invited to submit a cover letter and CV.

ADDITIONAL APPLICATION INFORMATION
The University of Texas MD Anderson Cancer Center is the nation's #1 ranked cancer center, located within the Texas Medical Center - home to 21 hospitals and 8 academic and research institutes. Houston is a large and vibrant city with an affordable cost of living, two major airports, professional sports teams, and cultural activities.

FACULTY MENTOR
Dr. Michael Wang